Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M-Powder
- Development stage
- Preclinical
- Lead developer
- Saisei Pharma
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral, Sublingual
01
Overview
M-Powder is an oral nutraceutical developed by Saisei Pharma that functions as a Gc protein-derived Macrophage Activating Factor (GcMAF). It is part of the company's 3rd Generation GcMAF product line and is produced through the degalactosylation of bovine whey protein using β-Galactosidase treatment. This enzymatic process converts vitamin D binding protein (VDBP) into a form that mimics the biological activity of GcMAF. The product is designed to activate macrophages and modulate the innate immune system, primarily through interaction with lymphoid tissues in the throat or via sublingual absorption. M-Powder is marketed as a dietary supplement to support immune function, cellular repair, and anti-aging effects, and it has been investigated in clinical research for its potential role in managing conditions such as COVID-19.
- Brand names
- M-Powder
- Other names
- MAF PowderGcMAFGc protein-derived Macrophage Activating Factordegalactosylated bovine whey protein
Beyond the preview
Go deeper on M-Powder.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on M-Powder.